Showing of 535 results
Oxford-Harrington Rare Disease Centre Invites Proposals for 2026 Award
Prestigious Scholar Award Accelerates Novel Therapies for Patients with Rare Diseases.
A Regional Powerhouse for Cancer Discovery and Patient Impact
Theodoros Teknos, MD, and Gary Schwartz, MD, discuss how a $25.5 million NCI grant renewal reinforces Case Comprehensive Cancer Center’s leadership in clinical trials, early detection, and cancer prevention across Northeast Ohio.
UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Results published in JAMA Oncology.
University Hospitals Seidman Cancer Center Researchers Develop Easy-to-Use Tool that can Identify High- and Low-Risk Metastatic Prostate Cancer Patients Earlier
Results published in Nature Communications.
Cleveland Researchers Discover Enzyme That Controls Both Weight Gain and Cholesterol Levels in Animal Models
New Study from University Hospitals and Case Western Reserve University published in Science Signaling.
Inside the Mind of a Leader: What’s Next for Infectious Disease Medicine?
Igho Ofotokun, MD, MSc shares his journey from Nigeria to becoming a leader in HIV research, highlighting how pivotal experiences shaped his career in infectious diseases and guided his work addressing both HIV and COVID-19.
UH Ventures Awards Three Technology Validation Startup Fund (TVSF) Awards
UH Research & Education Institute
